Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use

Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of use

US Patent 8962859 · Granted Feb 24, 2015

Estimated economic value: $566,405,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2025
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2024
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2024
Method and apparatus for treatment of cardiopulmonary arrest2023
Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonis2023
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agoni2023
N-cyano-7-azanorbornane derivatives and uses thereof2023
Benzimidazole derivatives and their uses2022
Colony stimulating factor-1 receptor (CSF-1R) inhibitors2022
Method and apparatus for treatment of cardiopulmonary arrest2021